Furthermore, the authors demonstrated that IKBKE did not alter mRNA levels of LATS1/2 in glioma cells but was directly bound to LATS1/2, and facilitated its polyubiquitin degradation. This evidence concerns the gene IKBKE and central nervous system cancer.